DERMATA THERAPEUTICS, INC. Basic Shares Outstanding (Weighted Average)
DERMATA THERAPEUTICS, INC. (DRMA) reported Basic Shares Outstanding (Weighted Average) of 4.02 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 4.02M shares, a 291.83% increase year-over-year.
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 3.86M shares, a 648.63% increase year-over-year.
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 1.13M shares, a 229.03% increase year-over-year.
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 1.03M shares, a 560.25% increase year-over-year.
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 926.19K shares, a 505.46% increase from fiscal 2024.
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 152.97K shares.
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2021 was 4.30M shares, a 125.13% increase from fiscal 2020.
- DERMATA THERAPEUTICS, INC. weighted average number of shares outstanding, basic for fiscal 2020 was 1.91M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 4.02M shares 10-Q · filed 2026-08-11 | 3.94M shares 10-Q · filed 2026-08-11 | 3.00M shares derived: average of 3 quarters · filed 2026-08-11 | 2.51M shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | 3.86M shares 10-Q · filed 2026-05-13 | 2.49M shares derived: average of 2 quarters · filed 2026-05-13 | 2.01M shares derived: average of 3 quarters · filed 2026-05-13 | 1.76M shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | 1.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 1.08M shares derived: average of 2 quarters · filed 2026-03-26 | 1.06M shares derived: average of 3 quarters · filed 2026-08-11 | 926.19K shares 10-K · filed 2026-03-26 | |
| 2025-09-30 | 1.03M shares 10-Q · filed 2025-11-14 | 1.03M shares derived: average of 2 quarters · filed 2026-08-11 | 858.01K shares 10-Q · filed 2025-11-14 | 728.02K shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | 1.03M shares 10-Q · filed 2026-08-11 | 772.40K shares 10-Q · filed 2026-08-11 | 628.54K shares derived: average of 3 quarters · filed 2026-08-11 | 510.27K shares derived: average of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | 515.47K shares 10-Q · filed 2026-05-13 | 5.15M shares 10-Q · filed 2025-05-14 | 429.56K shares derived: average of 2 quarters · filed 2026-05-13 | 338.19K shares derived: average of 3 quarters · filed 2026-05-13 | 270.56K shares derived: average of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | 343.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 249.56K shares derived: average of 2 quarters · filed 2026-03-26 | 188.92K shares derived: average of 3 quarters · filed 2026-03-26 | 152.97K shares 10-K · filed 2026-03-26 | |
| 2024-09-30 | 155.47K shares 10-Q · filed 2025-11-14 | 111.56K shares derived: average of 2 quarters · filed 2025-11-14 | 89.41K shares 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | 67.65K shares 10-Q · filed 2025-08-13 | 56.02K shares 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | 444.00K shares 10-Q · filed 2025-05-14 | ||||
| 2022-03-31 | 8.35M shares 10-Q · filed 2022-05-16 | ||||
| 2021-12-31 | 4.30M shares 10-K · filed 2022-03-28 | ||||
| 2021-03-31 | 1.91M shares 10-Q · filed 2022-05-16 | ||||
| 2020-12-31 | 1.91M shares 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |